{"rows":[{"id":2517,"title":"Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.","authors":"Mithoefer MC, Grob CS, Brewerton TD","journal":"The lancet. Psychiatry","publication_date":"2016-05-01","publication_year":2016,"doi":"10.1016/s2215-0366(15)00576-3","pubmed_id":"27067625","openalex_id":"https://openalex.org/W2334295439","source_url":"https://pubmed.ncbi.nlm.nih.gov/27067625/","substance_tags":"psilocybin","topic_tags":"Anxiety,PTSD,Addiction,End-of-Life Distress,Aging","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27067625","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27067625/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27067625","source_url":"https://pubmed.ncbi.nlm.nih.gov/27067625/","doi":"10.1016/s2215-0366(15)00576-3","pmid":"27067625","publication_date":"2016-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2511,"title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.","authors":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ","journal":"The lancet. Psychiatry","publication_date":"2016-07-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30065-7","pubmed_id":"27210031","openalex_id":"https://openalex.org/W2396675581","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27210031","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27210031","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","doi":"10.1016/s2215-0366(16)30065-7","pmid":"27210031","publication_date":"2016-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2510,"title":"Altered states: psilocybin for treatment-resistant depression.","authors":"Cowen P","journal":"The lancet. Psychiatry","publication_date":"2016-07-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30087-6","pubmed_id":"27210032","openalex_id":"https://openalex.org/W2398800790","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210032/","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27210032","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27210032/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27210032","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210032/","doi":"10.1016/s2215-0366(16)30087-6","pmid":"27210032","publication_date":"2016-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2505,"title":"Psilocybin: panacea or placebo?","authors":"Hendrie C, Pickles A","journal":"The lancet. Psychiatry","publication_date":"2016-09-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30103-1","pubmed_id":"27568263","openalex_id":"https://openalex.org/W2509877995","source_url":"https://pubmed.ncbi.nlm.nih.gov/27568263/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27568263","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27568263","source_url":"https://pubmed.ncbi.nlm.nih.gov/27568263/","doi":"10.1016/s2215-0366(16)30103-1","pmid":"27568263","publication_date":"2016-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2504,"title":"Question-based Drug Development for psilocybin.","authors":"Dijkstra FM, Jacobs GE, Cohen AF","journal":"The lancet. Psychiatry","publication_date":"2016-09-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30214-0","pubmed_id":"27568265","openalex_id":"https://openalex.org/W2516614311","source_url":"https://pubmed.ncbi.nlm.nih.gov/27568265/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27568265","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27568265","source_url":"https://pubmed.ncbi.nlm.nih.gov/27568265/","doi":"10.1016/s2215-0366(16)30214-0","pmid":"27568265","publication_date":"2016-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2503,"title":"Question-based Drug Development for psilocybin - Authors' reply.","authors":"Carhart-Harris RL, Nutt DJ","journal":"The lancet. Psychiatry","publication_date":"2016-09-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30217-6","pubmed_id":"27568266","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/27568266/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27568266","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27568266","source_url":"https://pubmed.ncbi.nlm.nih.gov/27568266/","doi":"10.1016/s2215-0366(16)30217-6","pmid":"27568266","publication_date":"2016-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":908,"title":"Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.","authors":"Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ","journal":"The lancet. Psychiatry","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/s2215-0366(24)00333-x","pubmed_id":"39667373","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39667373/","substance_tags":"psilocybin","topic_tags":"Systematic Review,Review Article,Safety","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39667373","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39667373/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39667373","source_url":"https://pubmed.ncbi.nlm.nih.gov/39667373/","doi":"10.1016/s2215-0366(24)00333-x","pmid":"39667373","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":311,"title":"Compassionate use of psilocybin for treatment-resistant depression in Germany.","authors":"Gründer G, Mertens LJ, Jungaberle A, Jungaberle H, Spangemacher M","journal":"The lancet. Psychiatry","publication_date":"2026-02-01","publication_year":2026,"doi":"10.1016/s2215-0366(25)00277-9","pubmed_id":"40976246","openalex_id":"https://openalex.org/W4414422524","source_url":"https://pubmed.ncbi.nlm.nih.gov/40976246/","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:40976246","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40976246","source_url":"https://pubmed.ncbi.nlm.nih.gov/40976246/","doi":"10.1016/s2215-0366(25)00277-9","pmid":"40976246","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}}],"total":8,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The lancet. Psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}